No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
NRXP NRX Pharmaceuticals
- 1.5000
- -0.0200-1.32%
Close Dec 20 16:00 ET
- 1.5200
- +0.0200+1.33%
Post 19:58 ET
18.14MMarket Cap-0.71P/E (TTM)
1.5500High1.4600Low380.13KVolume1.5500Open1.5200Pre Close571.22KTurnover4.13%Turnover RatioLossP/E (Static)12.09MShares7.333052wk High-0.96P/B13.81MFloat Cap1.100052wk Low--Dividend TTM9.20MShs Float769.9000Historical High--Div YieldTTM5.92%Amplitude1.1000Historical Low1.5020Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
NRX Pharmaceuticals Is Maintained at Buy by Ascendiant Capital
NRX Pharmaceuticals Price Target Raised to $45.00/Share From $44.00 by Ascendiant Capital
NRx Pharmaceuticals (NASDAQ: NRXP) Announces Participation in the NobleCon20 - Noble Capital Markets' Twentieth Annual Emerging Growth Equity Conference December 3-4, 2024
HC Wainwright & Co. Reiterates Buy on NRX Pharmaceuticals, Maintains $19 Price Target
Express News | NRX Pharmaceuticals (Nasdaq:Nrxp) Announces Publication of Paper Entitled "Quality Assurance of Depression Ratings in Psychiatric Clinical Trials"
NRx Pharmaceuticals (NASDAQ:NRXP) Announces Publication of Paper Entitled "Quality Assurance of Depression Ratings in Psychiatric Clinical Trials"
Heat List
US
Overall
Symbol
Price
% Chg
No Data